(PRWEB) June 25, 2012
The US Drug Watchdog says, "Our DePuy ASR recalled hip implant initiative is one of our most important recalled medical device initiatives of ever. Unfortunately, because of lack of publicity most recalled DePuy ASR recipients may not understand the sense of urgency. The settlements could be over $100,000 per victim. Because of this, we are strongly encouraging family members or loved ones of anyone receiving a hip implant between 2005 and early 2010 to ask if it was a DePuy ASR hip implant." According to court records the DePuy ASR hip implant was sold as the right hip implant for younger adults who wanted to have an active or athletic lifestyle. The US Drug Watchdog says, "We could believe there are tens of thousands of DePuy ASR hip implant victims in the US, and because of age, or not wanting to go through a hip replacement revision surgery again, they say nothing. Nothing is more important to us than trying to get them some meaningful help, that includes the best possible attorneys. At this point we do not care if the recalled DePuy ASR hip implant device has not yet failed. We want to make certain all recipients are identified, in the event of a premature failure down the road." For more information about the DePuy ASR hip implant recall please call the US Drug Watchdog at 866-714-6466, or contact the group via its web site at http://USDrugWatchdog.com
The US Drug Watchdog indicates symptoms of the recalled DePuy ASR hip implant failure include:
The US Drug Watchdog is the premier advocate for medical device recipients, and pharmaceutical safety in the United States. The group says, "We think it is vital to get all DePuy ASR recipients identified now, because in our opinion it is a very important way to protect their future." For more information please contact the US Drug Watchdog anytime at 866-714-6466, or contact the group via its web site at http://USDrugWatchdog.Com
DePuy ASR Case Number Ohio Southern Federal District Court Case Number MDL No. 2197
Read the full story at http://www.prweb.com/releases/2012/6/prweb9625440.htm.
Copyright©2012 Vocus, Inc.
All rights reserved